News - Posts

Biocon Biologics / News – Posts

Biocon’s Insulin Glargine Receives Regulatory Approval in Japan

Sat, 28-May-2016
Posted by: Biocon Biologics

Biocon Q4FY16 Net Profit at Rs 361 Cr Revenue Crosses Rs 1,000 Cr; Up 17% FY 16 Revenues up 14% at Rs 3,570 Cr Net Profit at Rs 896 Cr

Tue, 26-Apr-2016
Posted by: Biocon Biologics

Biocon Inks Co-Development & Commercialization Agreement with Lab PiSA for rh- Insulin in USA

Thu, 17-Mar-2016
Posted by: Biocon Biologics

Biocon Gets its First Generic Formulation Approval in EU; On Track to Launch Rosuvastatin Tablets in FY 17

Mon, 15-Feb-2016
Posted by: Biocon Biologics

Biocon Q3FY16 Net Profit Up 13% at Rs 103 Crore, EBITDA Increases 23% to Rs 209 Crore, Revenues at Rs 857 Crore, up by 10%

Thu, 21-Jan-2016
Posted by: Biocon Biologics

Biocon Announces Data from Key Studies for Insulin Tregopil

Thu, 21-Jan-2016
Posted by: Biocon Biologics

1
…
17
18
19